OMB Revisions Would Kill 16 Center core Grants, Ban New Ones, Slash Noncompeting Funds 10 Percent
In Brief: Charles Smart To Give Up Commission On Cancer Post, Kansas Surgeon To Become Fulltime Director
Chabner Object To Yarbro’s Remarks On Federal Role In Clinical Research
RFA On Hepatitis B Virus, Liver Cancer
Program Announcements Non-Invasive Detection Of Lung Cancer
Immunoassays For Isoenzymes
Physician Clinical Investigator Awards
Trending Stories
- The story of daraxonrasib is the ultimate hero’s journey
A narrative curve with twists, turns, intrigue, drama—and a blow to a mighty foe - As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - Pancreatic cancer breakthrough came from smart scientists making smart bets—not from politicization of science
- At Senate hearing, Brown’s El-Deiry and other witnesses say they were targeted for arguing that mRNA vaccine may be linked to cancer
- Pancreatic cancer finally starts to budge as daraxonrasib doubles overall survival
- Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.”
